Dr. Yifan Cheng Confirmed to Speak at 2023 Zhongguancun Life Science Park Innovation Summit on Cryo-EM Advancements

Seizing the historic opportunities presented by a new round of scientific and technological revolution and industrial transformation, Zhongguancun Life Science Park, as a key pillar of Beijing’s “Three Cities and One District” main platform for building an international science and technology innovation center, has invested in and constructed numerous biotechnology innovation platforms, attracting a wide array of industry players and fostering agglomeration advantages across the upstream and downstream segments of the industrial chain.On March 24, 2023, Zhongguancun Life Science Park Co., Ltd. joined forces with multiple technology platforms to co-host the “2023 Zhongguancun Life Science Park Technology Platform Industry-Research Innovation Summit.”, focusing on core areas such as “AI-enabled new drug development,” “breakthroughs in undruggable targets,” “biopharmaceutical evaluation,” and “clinical biospecimen banking and utilization,” we bring together industry leaders, investment experts, and leading/innovative entrepreneurs to integrate the entire chain of industry, academia, research, and application, thereby promoting the establishment of a multi-level, broad-spectrum, functional, and open support system for novel innovation technology platforms.

Cheng Yifan, Member of the U.S. National Academy of Sciences and the American Academy of Arts and SciencesConfirmed attendance at the 2023 Zhongguancun Life Science Park Technology Platform Industry-Research Innovation Summit, and will be present in the afternoon’sAt the 2023 Innovative Drugs and Innovative Technologies Forum—Special Session on Breakthroughs in Undruggable Targets, a presentation was delivered onSharing a Report on Advances in Cutting-Edge Cryo-Electron Microscopy Technologies.

Personal Profile

Member of the U.S. National Academy of Sciences and the American Academy of Arts and Sciences; Professor at UCSF; Scientific Advisor to Shuimu Future Sciences. Cheng Yifan was admitted to the Department of Physics at Wuhan University in 1978, where he earned his bachelor’s and master’s degrees. He received his Ph.D. from the Institute of Physics, Chinese Academy of Sciences, in 1991, and subsequently conducted postdoctoral research in Norway and Germany. In 1996, he transitioned into the field of structural biology, continuing his postdoctoral work in the United States and Japan. He joined Harvard Medical School in 1999. In 2006, he moved to the University of California, San Francisco (UCSF), as an Assistant Professor. He was granted tenure in 2012. In 2015, he became an Investigator at the Howard Hughes Medical Institute. He was elected to the American Academy of Arts and Sciences in 2019 and to the U.S. National Academy of Sciences in 2020.

Innovative Drugs and Innovative Technologies Forum 2023 – Breaking Through Undruggable Targets

How can we leverage clinical sample analysis and proteomics to identify innovative targets with high disease relevance? How can we utilize high-resolution protein crystal structure determination platforms to gain insights into the druggability of these targets? How can we integrate drug design, drug screening, and multidimensional drug evaluation platforms to pave new avenues for the development of therapies targeting difficult-to-drug targets?

This forum will explore frontier technologies and address the practical needs of the industry, providing insights into the latest technological advances, druggable targets, new drugs, and molecular mechanisms.

Core Topics

1. ATTEC: Autophagy-Lysosome-Targeting Molecular Glue Degraders

2. Highly Efficient and Stable TPD Proteomics Analysis Protocol

3. Innovation-Driven New Drug Development

More topics are being confirmed. Stay tuned...

This summit is organized byUnder the guidance of the Administrative Committee of Zhongguancun Life Science Park, Zhongguancun Life Science Park Company, Zhongguancun Life Science Park Incubator Company, and Changfa Zhan CompanyJointSix Core Biotechnology Innovation Platforms: Zhongguancun AI Drug Discovery Platform, Beijing Public Service Platform for Clinical Data and Sample Resources, Cryo-Electron Microscopy Platform, High-Resolution Mass Spectrometry Omics Platform, Biopharmaceutical Evaluation Platform, and Integrated Biological CRO Service Platform, by focusing on core aspects of pharmaceutical R&D such as basic research, target discovery, pilot-scale development, and drug analysis, we can further unlock the industry's potential, better foster the continuous growth of various new business models, and promote high-quality development in the field of life sciences and technology.

AsThe First Grand Event Jointly Hosted by Zhongguancun Life Science Park and Its Technical Platform, this summit is themed1 Main Forum + 4 Thematic Sub-forumsin a format that further ensures the depth, breadth, cutting-edge nature, and richness of resources. The main forum will serve as a platform to centrally showcase the insights of industry participants, with numerous industry leaders engaging in aOn Biotechnology Across Multiple Fields, Including Laboratory Animals and Viral Infections"Brainstorming." The sub-forum focuses on"High-Quality Construction and Sustainable Development of Biobank Resources," "AI-Empowered Innovative Drug R&D," "Breakthroughs in Undruggable Targets," and "Evaluation of Biologic Drugs": Four Key DimensionsIn-Depth Analysis of Innovation and High-Quality Development Pathways and Strategies in Biopharmaceutical Technology

CompilationOver 40 national academicians, heads of regulatory agencies, leading academics, executives of multinational pharmaceutical companies, directors of Grade A tertiary hospitals, and seasoned investorsfeaturing prominent guests, coveringThe Six Major Spheres: Government, Industry, Academia, Research, Healthcare, and Investment, bringing together new ideas, new technologies, and new business models; focusing on pressing industry issues; jointly seeking truth and insights; and engaging in comprehensive, high-level, high-quality, and forward-looking sharing and discussions.

Scan the QR code to learn more about the conference and register now.